Article Details

Enara Bio to present progress of research on novel, cancer-specific, MR1-restricted TCRs at ...

Retrieved on: 2021-06-09 08:26:15

Tags for this article:

Click the tags to see associated articles and topics

Enara Bio to present progress of research on novel, cancer-specific, MR1-restricted TCRs at .... View article details on hiswai:

Excerpt

MR1 is an unconventional HLA-like target that appears to present cancer-specific, metabolite ligands to the immune system. Enara Bio are developing ...

Article found on: www.pharmiweb.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up